Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Jan 15, 2010 (Vol. 30, No. 2)

MethPrimer

URL:www.urogene.org/methprimer/index.html
  • Nice resources in addition to the primer tool itself
  • Bland web design, some of the text doesn't display correctly

Well, it’s not the prettiest website, but who ever said that primer websites had to be pretty, right? MethPrimer is a straightforward program for designing bisulfite-conversion-based methylation PCR primers, either for methylation-specific PCR (MSP) or bisulfite-sequencing PCR (BSP)/bisulfite-restriction PCR. The primer design program is pretty standard—paste a DNA sequence, choose parameters, and (ta-da!) you have primers. However, the other features of this site are what really make it worthwhile to visit. There are a number of links to protocols and other online resources (although, annoyingly, some of the links don’t take you to the specific page you need), as well as a methylation method forum. Whether you wish to lend your expertise to the H3 hyper-methylation question, or you’re wondering how to cleanup your amplicons, the forum is the place to go.

  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »